Question 1

Does Driehaus Capital Management own BBIO stock?

Accepted Answer

No. Driehaus Capital Management exited its BBIO (Bridgebio Pharma) position in Q2 2026. Its Q1 2026 13F listed 1,146,671 shares worth $85.2M.

Question 2

How many shares of BBIO does Driehaus Capital Management own?

Accepted Answer

None since Q2 2026, when Driehaus Capital Management exited the position. Its Q1 2026 13F listed 1,146,671 shares worth $85.2M.

Question 3

What is Driehaus Capital Management's BBIO position worth?

Accepted Answer

Driehaus Capital Management's BBIO position was worth $85.2M in its Q1 2026 13F, before the exit in Q2 2026.

Question 4

Is Driehaus Capital Management buying or selling BBIO?

Accepted Answer

In Q2 2026, Driehaus Capital Management exited its entire BBIO position.

Question 5

When did Driehaus Capital Management first buy BBIO?

Accepted Answer

Driehaus Capital Management first reported BBIO in its Q1 2025 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$74.48	0
2026-Q1	Decreased	1.1M	-31.8%	$85.2M	0.6%	$74.26	0
2025-Q4	Increased	1.7M	+1.1%	$128.6M	0.9%	$76.49	43
2025-Q3	Decreased	1.7M	-1.7%	$86.3M	0.6%	$51.94	0
2025-Q2	Increased	1.7M	+12.7%	$73M	0.6%	$43.18	47
2025-Q1	New	1.5M	-	$51.9M	0.5%	$34.57	57

BBIO6 quarters

BBIO
6 quarters